0001179110-21-008096.txt : 20210810
0001179110-21-008096.hdr.sgml : 20210810
20210810190137
ACCESSION NUMBER: 0001179110-21-008096
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20210806
FILED AS OF DATE: 20210810
DATE AS OF CHANGE: 20210810
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Simantov Ronit
CENTRAL INDEX KEY: 0001871563
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35890
FILM NUMBER: 211161501
MAIL ADDRESS:
STREET 1: 1988 CHAPEL STREET
CITY: NEW HAVEN
STATE: CT
ZIP: 06515
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Tempest Therapeutics, Inc.
CENTRAL INDEX KEY: 0001544227
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 451472564
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 7000 SHORELINE COURT
STREET 2: SUITE 275
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 415-798-8589
MAIL ADDRESS:
STREET 1: 7000 SHORELINE COURT
STREET 2: SUITE 275
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
FORMER COMPANY:
FORMER CONFORMED NAME: Millendo Therapeutics, Inc.
DATE OF NAME CHANGE: 20181207
FORMER COMPANY:
FORMER CONFORMED NAME: OvaScience, Inc.
DATE OF NAME CHANGE: 20120308
3
1
edgar.xml
FORM 3 -
X0206
3
2021-08-06
1
0001544227
Tempest Therapeutics, Inc.
TPST
0001871563
Simantov Ronit
TEMPEST THERAPEUTICS, INC.
7000 SHORELINE COURT, SUITE 275
SOUTH SAN FRANCISCO
CA
94080
1
0
0
0
/s/ Pierre Lorenzo (Attorney-in-Fact)
2021-08-10
EX-24
2
ex24ronit.txt
POWER OF ATTORNEY
Know all by these presents, that the undersigned hereby constitutes and
appoints Stephen Brady, Nicholas Maestas and Pierre Lorenzo of Tempest
Therapeutics, Inc. and Laura Berezin,Sepideh Mousakhani, Noel Ripberger-Scheick
and Nguyen X. Nguyen of Cooley LLP, or any of them signing singly, with full
power of substitution, the undersigned's true and lawful attorney in fact to:
(1) execute for and on behalf of the undersigned, in the undersigned's
capacity as an officer, director or beneficial owner of more than 10% of a
registered class of securities of Tempest Therapeutics, Inc. (the "Company"),
Forms 3, 4, and 5 (including any amedments thereto) in accordance with
Section 16(a) of the Securities Exchange Act of 1934, as amended (the "Exchange
Act") and the rules thereunder and a Form ID, Uniform Application for Access
Codes to File on EDGAR.
(2) do and perform any and all acts for an on behalf of the undersigned
that may be necessary or desirable to execute such Form 3,4 or 5, or Form ID
(including any amendments thereto) and timely file such forms with the United
States Securities and Exchange Commission and any stock exchange or similar
authority; and
(3) take any other action of any nature whatsoever in connection with the
foregoing which, in the opinion of such attorney-in-fact, may be of benefit, in
the best interest of, or legally required by, the undersigned, it being
understood that the documents executed by such attorney-in-fact on behalf of the
undersigned pursuant to this Power of Attorney shall be in such form and shall
contain such terms and conditions as such attorney-in-fact may approve in such
attorney-in-fact's discretion.
The undersigned hereby grants to each such attorney-in-fact full power and
authority to do and perform any and every act and thing whatsoever requisite,
necessary, or proper to be done in the exercise of any of the rights and powers
herein granted, as fully to all intents and purposes as the undersigned might or
could do if personally present, with full power of substitution or revocation,
hereby ratifying and confirming all that such attorney-in-fact, or such
attorney-in-fact's substitute or substitutes, shall lawfully do or cause to be
done by virtue of this power of attorney and the rights and powers herein
granted. The undersigned acknowledges that the foregoing attorneys-in-fact, in
serving in such capacity at the request of the undersigned, are not assuming,
nor is the Company assuming, any of the undersigned's responsibilities to comply
with Section 16 of the Exchange Act.
This Power of Attorney shall remain in full force and effect until the
earliest to occur of (a) the undersigned is no longer required to file Forms 3,
4 and 5 with respect to the undersigned's holdings of and transactions in
securities issued by the Company, (b) revocation by the undersigned in a signed
writing delivered to the foregoing attorneys-in-fact, or (c) as to any
attorney-in-fact individually, until such attorney-in-fact shall no longer be
employed by the Company or Cooley LLP.
IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to
be executed as of this date: 8/7/2021.
/s/ Ronit Simantov
---------------------------
Ronit Simantov